title: Central nervous system manifestations after steroid pulse therapy in systemic lupus erythematosus.
authors.forename: Yuichi
authors.initials: Y
authors.lastname: Tabata
authors.forename: Kobayashi
authors.initials: K
authors.lastname: Ichiro
authors.forename: Nobuaki
authors.initials: N
authors.lastname: Kawamura
authors.forename: Motohiko
authors.initials: M
authors.lastname: Okano
authors.forename: Kunihiko
authors.initials: K
authors.lastname: Kobayashi
mesh_terms: D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001921:Brain / Q000473:pathology; D002490:Central Nervous System / Q000187:drug effects* / Q000473:pathology; D002648:Child; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy* / Q000473:pathology; D008279:Magnetic Resonance Imaging; D008775:Methylprednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D018696:Neuroprotective Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D020551:Pulse Therapy, Drug
chemical_list: D000893:Anti-Inflammatory Agents; D018696:Neuroprotective Agents; D008775:Methylprednisolone